Location: Home
  • search
  • go
  • Relate News
  • 5/9/2019Recent Chinese Study links Diabetes and Numerous Cancers
  • 5/9/2019Amerigen Announces USFDA Approval for Generic Penicillamine
  • 5/9/2019Progressive Reforms Shifting the Cancer Medicine Landscape in China
  • 5/9/2019Alembic Pharma Forms Chinese Joint Venture
  • 5/8/2019Chinese Pharma Billionaire Paid $6.5M to Get Daughter into Stanford
  • 5/8/2019Research Point Global and WuXi CDS to Rebrand as WuXi Clinical
  • 5/8/2019Merck's Successful First Quarter Largely Driven by China Growth
  • 5/8/2019CDE Publicizes Four More Drug Applications To Be Granted Priority Revi...
  • 5/8/2019NMPA Announces Package Insert Revision of Bromocriptine Mesylate Table...
  • 5/6/2019China's Conditional Approval of Bayer's Acquisition of Monsanto: Lesso...
  • 5/6/2019Sun Pharma Eyes China Expansion with A Local Partner
  • 5/6/2019Pre-revenue Tot Biopharma Files for Listing in Hong Kong
  • 5/6/2019WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Cli...
  • 5/6/2019Bayer's Pharma Sales in Q1/2019 Benefited from Volume Growth of Some D...
  • 5/5/2019China Pilots Program to Regulate Medical Services by Dynamic Means
  • 5/5/2019China Promote IT Application in Community Healthcare Facilities
  • 5/3/2019Immunomedics and Everest Medicines Announce License Agreement for Saci...
  • 5/3/2019Chinese Hospitals Set to Sell Experimental Cell Therapies
  • 5/3/2019Some Big Pharma Cos Raise 2019 Outlook Driven by China Prospects and N...
  • 5/3/2019Kangmei's $4bn Accounting Error Highlights China Risk
  • 5/1/2019IQVIA Report Provides A Brids-Eye-View of Chinese Drug Market for NCDs
  • 5/1/2019Review of U.S. ANDAs from Chinese Pharma Companies in 2019
  • 5/1/2019SMEI: Fastest Growing Products in the Top 200 Drugs by Sales Value in ...
  • 5/1/2019China to Face Repercussions of Irrational Cost Cutting as It Gets Read...
  • 4/30/2019Financial-related Company News in Brief
  • 4/30/2019NMPA Announces the Authorizations of Four HK Hospitals to Undertake Ma...
  • 4/30/2019NMPA Approves Sinovant's Clinical Trial Application for Derazantinib
  • 4/30/2019AstraZeneca Sees Robust Anticancer Sales Growth, Driven by China and J...
  • 4/30/2019China Money Helps Congenica Raise Extra Funds to Scale in China and U....
  • 4/30/2019Roche's Rituxuan Faces Chinese Biosimilar Challenge from Fosun Pharma
  • Page:317/808 Total number of articles:24233: [First][<<] [315] [316] [317] [318] [319] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group